View Exam | PowerPak

1. Compared with healthcare-associated C. difficile infections, community-associated C. difficile infections are:

A. Less severe B. More likely to recur C. More prevalent D. Attributed to virulent strains

2. Which of the following best describes recommendations for the treatment of adults with an initial mild-moderate episode of C. difficile infection in the 2017 IDSA/SHEA clinical practice guidelines?

A. Metronidazole, vancomycin, and fidaxomicin are recommended with no preference for any agent B. Metronidazole and vancomycin are recommended over fidaxomicin C. Vancomycin and fidaxomicin are recommended over metronidazole D. Metronidazole is recommended over vancomycin and fidaxomicin

3. In comparison with vancomycin, fidaxomicin has been associated with less risk of recurrence. This has been attributed to:

A. Greater systemic bioavailability of fidaxomicin B. Less impact on colonization resistance with fidaxomicin C. The fact that fidaxomicin is a broad-spectrum antibiotic D. Less resistance to fidaxomicin

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Compared with healthcare-associated C. difficile infections, community-associated C. difficile infections are:

2. Which of the following best describes recommendations for the treatment of adults with an initial mild-moderate episode of C. difficile infection in the 2017 IDSA/SHEA clinical practice guidelines?

3. In comparison with vancomycin, fidaxomicin has been associated with less risk of recurrence. This has been attributed to:

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Compared with healthcare-associated C. difficile infections, community-associated C. difficile infections are:

2. Which of the following best describes recommendations for the treatment of adults with an initial mild-moderate episode of C. difficile infection in the 2017 IDSA/SHEA clinical practice guidelines?

3. In comparison with vancomycin, fidaxomicin has been associated with less risk of recurrence. This has been attributed to:

« Return to Activity

Customers who Purchased
this Activity also Purchased